Pando Bioscience
AI-driven synthetic biology company that discovers and designs high-performance enzymes with AI-guided iterative improvement for pharma manufacturing and life science tools.
About Pando Bioscience
Pando is an AI-driven synthetic biology company revolutionizing enzyme engineering for the pharmaceutical industry. Our ultra-high-throughput screening platform screens 1000-fold more enzymes 75% faster and 80% cheaper than traditional methods. This empowers our generative AI to efficiently optimize enzymes across multiple properties, delivering high-performing, tailored enzymes that reduce costs and enhance efficiency.
Products
Family of newly discovered Phi29-like polymerases (Saiyan-Phi1, Saiyan-Phi2) for amplification and sequencing.
Proprietary AI platform with its own models, experimental training data, and an integrated wet-lab loop, covering the design-build-test-learn workflow for enzyme discovery.
Engineered version of the wild-type phage Phi29 DNA polymerase with increased activity, increased thermostability, and reduced error rate.
Tailored enzyme discovery and engineering, including small-molecule biocatalysis and DNA/RNA modifying enzymes.
Ultra-high-throughput droplet screening, in-house build, and instrument-grade validation generating proprietary training data for AI models.
Security and compliance
As reported by Pando Bioscience. Ask for audit reports before you buy.
- SOC 2 Type IICompliant
- Essential cookies for site functionality
- Google Analytics loads only after cookie-notice acknowledgement
- Hosting provider records server-side diagnostics; full IP address not retained
- Does not sell personal information
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim Pando Bioscience